Main Article Content
Reduced water solubility causes drugs to dissolve slowly and absorb poorly, leading to low bioavailability. Solubility is an important factor to consider during the design and research process because most medications are weakly acidic and weakly basic. Appropriate studies and techniques are required to improve drug solubility and thus bioavailability and therapeutic effects. This review briefly explores particle size reduction, inclusion complexes, co-solvency, microemulsion, spray drying, nanotechnology, and other solubility enhancement techniques, as well as a comparison study of techniques based on research study. In conclusion, even though all solubility enhancement techniques are effective and have the potential to improve solubility, they each have their own set of advantages and disadvantages. As a result, stating any technique is superior to another is unfeasible.
Boylan JC, Swarbrick J, editors. Encyclopedia of pharmaceutical technology. Marcel Dekker; 2001.
Shargil L, Yu AB. Applied Biopharmaceutics. Appleton-Century Crofts Norwalk C.T. 1985; 193-203.
IUPAC gold book.
[Cited 2021 Apr 20].
Martin A, Bustamanate P, Chun AHC. Physical Pharmacy. New Delhi: B I Waverly Private Limited. 1994;223.
Osol A. editor. In: Remington’s Pharmaceutical Sciences. Eastern Pennsylvania: Mack Publishing Company. 1990;203.
Krishnaiah YSR. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. Journal of Bioequivalence & Bioavailability. 2010;2(2):28-36.
Kadam SV, Shinkar DM, Saudagar RB. Review on solubility enhancement techniques. IJPBS. 2013;3(3):462-475.
Kerns EH, Li Di. Drug like properties: Concept, structure, design and methods, from ADME to toxicity optimization. Elsevier. 2008; 56.
Kufe DW, Pollack RE, Weichselbaum RR, et al. editors. Holland-Frei cancer medicine. 6th ed. Hamilton (ON): BC Decker; 2003.
Alavijeh MS, Chishty M, Qaiser MZ, et al. Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx: The journal of the American Society for Experimental Neuro Therapeutics. 2005;2(4):554-571.
Di Piro JT, Spruill WJ, Wade WE, et al. Concepts in clinical pharmacokinetics, American Society of Health-System Pharmacists. Inc.: Bethesda MD; 2010.
Swarbrick J. Encyclopedia of Pharmaceutical Technology: Volume 6. CRC Press; 2013.
Chauhan NN, Patel NV, Suthar SJ, et al. Micronization of BCS class II drugs by various approaches for solubility enhancement: A review. Research Journal of Pharmacy and Technology. 2012;5(8):999-1005.
Kumar S, Bhargava D, Thakkar A, et al. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2013;30(3).
Vinarov Z, Katev V, Radeva D, et al. Micellar solubilization of poorly water-soluble drugs: effect of surfactant and solubilizate molecular structure. Drug Development and Industrial Pharmacy. 2018;44(4):677-686.
Jagtap S, Magdum C, Jadge D, et al. Solubility enhancement technique: A review. Journal of Pharmaceutical Sciences and Research. 2018;10(9):2205-2211.
Nigade PM, Patil SL, Tiwari SS. Self emulsifying drug delivery system (SEDDS): A review. International Journal of Pharmacy and Biological Sciences. 2012;2(2):42-52.
Sekiguchi K, Obi N. Studies on absorption of eutectic mixtures. I.A. Comparison of the behaviour of eutectic mixtures of sulphathiazole and that of ordinary sulphathiazole in man. Chemical and Pharmaceutical Bulletin. 1961;9:866-872.
He Y, Ho C. Amorphous solid dispersions: Utilization and challenges in drug discovery and development. Journal of pharmaceutical Sciences. 2015;104(10):3237-3258.
Kumar P, Singh C. A study on solubility enhancement methods for poorly water soluble drugs. American Journal of Pharmacological Sciences. 2013;1(4):67-73.
Jain P, Goel A, Sharma S, et al. Solubility enhancement techniques with special emphasis on hydrotrophy. International Journal of Pharma Professional's Research. 2018;1(1):34-45.
Ahmad Z, Maurya N, Mishra KS, et al. Solubility enhancement of poorly water soluble drugs: A review. International Journal of Pharmaceutical Technology. 2011; 3(1):807-823.
Riehemann K, Fuchs H, Schneider SW, et al. Nanomedicine-challenge and perspectives. Angewandte Chemie International Edition in English. 2009;48:872-897.
Nagabandi VK, Ramarao T, Jayaveera KN. Liquisolid compacts: A novel approach to enhance bioavailability of poorly soluble drugs. International Journal of Pharmacy and Biological Sciences. 2011;89-102.
Lu M, Xing H, Jiang J, et al. Liquisolid technique and its applications in pharmaceutics. Asian Journal of Pharmaceutical Sciences. 2017;12(2):115-123.
Chella N, Shastri N, Tadikonda RR. Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan. Acta Pharmaceutica Sinica B. 2012;2(5):502-508.
Bruno TJ, Ely JF. Supercritical fluid technology (1991): Reviews in modern theory and applications. CRC Press; 2017
Parhi R, Suresh P. Supercritical fluid technology: a review. Journal of Advanced Pharmaceutical Science and Technology. 2013; 1(1):13-36.
Jadhav YL, Parashar B, Ostwal PP, et al. Solid dispersion: Solubility enhancement for poorly water soluble drug. Research Journal of Pharmacy and Technology. 2012;5(2):190-197.
Patel M, Tekade A, Gattani S, et al. Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques. AAPS PharmSciTech 2008;9:1262–1269.
Priestly E. Introduction to liquid crystals. Springer Science & Business Media; 2012.
Collings PJ, Goodby JW. Introduction to liquid crystals: chemistry and physics. Crc Press; 2019.
Rizwan SB, McBurney WT, Young K, et al. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses. Journal of Controlled Release. 2013; 165(1):16–21.
Kumar S, Singh P. Various techniques for solubility enhancement: An overview. The Pharma Innovation. 2016;5(1, Part A):23-28.
Nagapudi K, Jona J. Amorphous active pharmaceutical ingredients in preclinical studies: Preparation, characterization, and formulation. Current Bioactive Compounds 2008;4(4):213–224.
Katti KS, Katti DR, Ambre AH. Nanocomposites for bone tissue engineering. Nanotechnologies for the Life Sciences; 2012.
Khan I, Khan MI, Khan U. Liquisolid technology: An emerging and advance technique for enhancing solubilization. PharmaTutor. 2014; 2(6);31-41.
Dontireddy R, Crean AM. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions. Drug Development and Industrial Pharmacy. 2011;37(10):1141–49.
Biradar S, Patil A, Guditi S, et al. A comparative study of approaches used to improve solubility of roxithromycin. Powder Technology. 2006;169(1):22–32.
Singh G, Sharma S, Gupta GD. Extensive diminution of particle size and amorphization of a crystalline drug attained by eminent technology of solid dispersion: a comparative study. AAPS Pharm Sci Tech. 2016;18(5): 1770–1784.
De Mohac LM, Caruana R, Cavallaro G, et al. Spray-drying, solvent-casting and freeze-drying techniques: a comparative study on their suitability for the enhancement of drug dissolution rates. Pharmaceutical Research. 2020;37(3):1-11.
Zeng N, Gao X, Hu Q, et al. Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: Cellular interaction and in vivo absorption. International Journal of Nanomedicine 2012; 7:3703-3718.
Lai J, Chen J, Lu Y, et al. Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. AAPS Pharm Sci Tech. 2009;10(3):960–966.
Ganesan P, Soundararajan R, Shanmugam U, et al. Development, characterization and solubility enhancement of comparative dissolution study of second generation of solid dispersions and microspheres for poorly water soluble drug. Asian Journal of Pharmaceutics. 2015;10(5):433–441.
Khan A, Iqbal Z, Shah Y, et al. Enhancement of dissolution rate of class II drugs (Hydrochlorothiazide); a comparative study of the two novel approaches; solid dispersion and liqui-solid techniques. Saudi Pharmaceutical Journal. 2015;23(6):650–657.
Lakshmi PK, Srinivas Ch, Kalpana B. Preparation and comparative evaluation of liquisolid compacts and solid dispersions of valsartan. Stamford Journal of Pharmaceutical Sciences. 2012;4(2):48-57.
Mahmah O, Tabbakh R, Kelly A, et al. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine. Journal of Pharmacy and Pharmacology. 2013;66(2):275–284.
Hanafy A, Spahn-Langguth H, Vergnault G, et al. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Advanced Drug Delivery Reviews. 2007;59(6):419-426.
Park MJ, Ren S, Lee BJ. In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble self‐emulsifying system and in solid dispersion. Biopharmaceutics & Drug Disposition. 2007;28(4):199-207.